BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Amniocentesis
,
Doxycycline
,
rs3825942
,
CYP51
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphatidylinositol phosphate phosphatase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pharyngeal mucosa
Tongue main corpus
Hypothalamus
Duodenum
Nipple cross-section
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Multiple-resistant Staphylococcus aureus infection
Pyloric ulcer
Tularemia
Alpha-1-antitrypsin deficiency
Bacterial infection due to Bacillus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
A 443654
Apitolisib
neratinib
GSK690693
STA 9090
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCDH11X
PPRC1
CRKL
HADH
NCL
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Pheochromocytoma and paraganglioma miRNA profiles
Embryonic kidney cells overexpressing mutant DROSHA in a Wilms tumor model
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
Y79 retinoblastoma cells: control vs. curcumin treated
MicroRNA expression profiling of human adrenal pheochromocytomas
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for phosphatidylinositol phosphate phosphatase activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ